- Home
- PEBK vs INO Comparison
PEBK vs INO Comparison
Compare PEBK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- INO
- Stock Information
- Founded
- PEBK 1912
- INO 1979
- Country
- PEBK United States
- INO United States
- Employees
- PEBK N/A
- INO N/A
- Industry
- PEBK Major Banks
- INO Medical/Dental Instruments
- Sector
- PEBK Finance
- INO Health Care
- Exchange
- PEBK Nasdaq
- INO Nasdaq
- Market Cap
- PEBK 162.7M
- INO 136.6M
- IPO Year
- PEBK N/A
- INO 1998
- Fundamental
- Price
- PEBK $30.51
- INO $2.58
- Analyst Decision
- PEBK
- INO Buy
- Analyst Count
- PEBK 0
- INO 5
- Target Price
- PEBK N/A
- INO $8.80
- AVG Volume (30 Days)
- PEBK 5.7K
- INO 1.0M
- Earning Date
- PEBK 10-20-2025
- INO 11-10-2025
- Dividend Yield
- PEBK 3.15%
- INO N/A
- EPS Growth
- PEBK 3.81
- INO N/A
- EPS
- PEBK 3.06
- INO N/A
- Revenue
- PEBK $85,500,000.00
- INO $182,337.00
- Revenue This Year
- PEBK N/A
- INO N/A
- Revenue Next Year
- PEBK N/A
- INO $14,751.49
- P/E Ratio
- PEBK $10.10
- INO N/A
- Revenue Growth
- PEBK 6.88
- INO N/A
- 52 Week Low
- PEBK $23.74
- INO $1.30
- 52 Week High
- PEBK $33.90
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- PEBK 49.06
- INO 58.30
- Support Level
- PEBK $29.16
- INO $2.21
- Resistance Level
- PEBK $31.95
- INO $2.49
- Average True Range (ATR)
- PEBK 0.70
- INO 0.14
- MACD
- PEBK 0.13
- INO -0.01
- Stochastic Oscillator
- PEBK 55.13
- INO 81.29
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.